Ninety One UK Ltd Makes New $18.61 Million Investment in Humana Inc. $HUM

Ninety One UK Ltd purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 71,543 shares of the insurance provider’s stock, valued at approximately $18,613,000. Ninety One UK Ltd owned about 0.06% of Humana at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in HUM. Vanguard Group Inc. increased its position in Humana by 1.6% during the second quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider’s stock worth $3,471,395,000 after acquiring an additional 226,224 shares during the period. Dodge & Cox lifted its holdings in shares of Humana by 5.6% in the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock worth $2,775,562,000 after acquiring an additional 597,705 shares during the last quarter. State Street Corp boosted its position in Humana by 1.1% in the second quarter. State Street Corp now owns 5,377,390 shares of the insurance provider’s stock valued at $1,319,334,000 after buying an additional 58,094 shares in the last quarter. Pzena Investment Management LLC lifted its stake in shares of Humana by 6.5% in the 2nd quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock valued at $996,664,000 after acquiring an additional 247,744 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Humana by 1.9% during the second quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider’s stock valued at $762,233,000 after purchasing an additional 57,267 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Down 1.0%

Shares of Humana stock opened at $256.35 on Friday. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The company has a 50-day simple moving average of $256.02 and a two-hundred day simple moving average of $260.84. The stock has a market capitalization of $30.83 billion, a PE ratio of 24.03, a price-to-earnings-growth ratio of 1.50 and a beta of 0.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The firm had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the business posted $4.16 EPS. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Analyst Ratings Changes

Several brokerages have commented on HUM. Guggenheim reaffirmed a “buy” rating on shares of Humana in a report on Friday, October 3rd. Wolfe Research dropped their target price on shares of Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research report on Thursday, November 20th. Robert W. Baird reduced their price objective on Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Finally, Wells Fargo & Company raised their target price on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Nine equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $294.32.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.